C4 Therapeutics, Inc. · NASDAQ:CCCC
Grogan Donna Roy received 4,618 C4 Therapeutics, Inc. shares as an award (Form 4)
Traded Oct 1, 2026 · Filed Oct 2, 2026
On Oct 1, 2026, Grogan Donna Roy (Director) received 4,618 C4 Therapeutics, Inc. shares as an award at US$3.14 for US$14,501, leaving 79,471 shares. Filed Oct 2, 2026 (Form 4).
- Awarded
- 4,618 shares
- Price
- US$3.14
- Value
- US$14,501
- Holding after
- 79,471 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Award | 4,618 | US$3.14 | 79,471 | Direct |
Source
Related
- C4 Therapeutics, Inc.
- Grogan Donna Roy
- C4 Therapeutics, Inc. shareholders
- Form 4 · Grogan Donna Roy · Jul 2, 2026
- Form 4 · Grogan Donna Roy · Apr 3, 2026
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026